1. The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC)
   Ping-Chih Hsu et al, 2020, Cancers CrossRef
2. Fractalkine/CX3CL1 in Neoplastic Processes
   Jan Korbecki et al, 2020, International Journal of Molecular Sciences CrossRef
3. K-Homology Type Splicing Regulatory Protein: Mechanism of Action in Cancer and Immune Disorders
   Jonathan D. Leavenworth et al, 2024, Critical Reviews in Eukaryotic Gene Expression CrossRef
4. Proteomics as a Complementary Technique to Characterize Bladder Cancer
   Rubén López-Cortés et al, 2021, Cancers CrossRef
5. Systematic Analysis and Identification of Molecular Subtypes of TRP-Related Genes and Prognosis Prediction in Lung Adenocarcinoma
   Yang Guo et al, 2022, Journal of Oncology CrossRef
6. The Role of Chemokines in Cervical Cancers
   Fabian Garrido et al, 2021, Medicina CrossRef
7. Uncovering the Anti-Lung-Cancer Mechanisms of the Herbal Drug FDY2004 by Network Pharmacology
   Ho-Sung Lee et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
8. Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer
   Xinjie Lu, 2022, Current Medicinal Chemistry CrossRef
9. A systematic pan-cancer analysis reveals the clinical prognosis and immunotherapy value of C-X3-C motif ligand 1 (CX3CL1)
   Yidi Sun, 2023, Frontiers in Genetics CrossRef
10. Natural Compounds as Target Biomolecules in Cellular Adhesion and Migration: From Biomolecular Stimulation to Label-Free Discovery and Bioactivity-Based Isolation
    Beatrix Péter et al, 2021, Biomedicines CrossRef
11. Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients
    Valentina Marchica et al, 2019, Cancers CrossRef
12. Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator
    Xinyan Li et al, 2022, Frontiers in Oncology CrossRef